BC Platforms has launched a resource that enables integrated analytics of genomic and clinical data.

The resource, BC|RQUEST, facilitates browsing and analytics of genomic and clinical data that has been aggregated across biobanks and streamlines collaboration between biobanks and the pharmaceutical industry.  Microsoft will provide the cloud infrastructure for indexing and accessing the information globally and securely through the Microsoft Azure cloud platform.  It will be used by members of the Open Biobank Research Enhancement Alliance (OBREA), formed by BC Platforms to connect biobanks, technology enablers, researchers and industry.

Biobanks joining at this initial phase are geographically diverse, from Estonia, Mexico, Finland, Poland, the United States and the UK, representing more than 2 million people.  BC Platforms’ vision is to build the world’s leading analytics resource for healthcare and industry by 2020, providing access to diverse genomic and clinical data from biobanks, comprising more than 5 million people.

“Genomic data is notoriously difficult to collect, harmonise and integrate with phenotypic data on a global scale. Through this initiative we make it possible for researchers to immediately access the combined data assets of a global network of biobanks, saving them the time and expense involved in locating suitable samples and harmonizing multiple sources of data.  In addition, through participation in the network, biobanks can support their operations and enhancements as well as experience a best practice approach to data management and sharing,” said Tero Silvola, CEO of BC Platforms.